Try Alerts Free   |   Login
Health Care › Biological Products (No Diagnostic Substances)

ADPT Price Correlated With Financials For Adaptive Biotechnologies

Free historical financial statements for Adaptive Biotechnologies Corp. See how revenue, income, cash flow, and balance sheet financials have changed over 11 quarters since 2020. Compare with ADPT stock chart to see long term trends.

ADPT Stock Compared to Quarterly

ADPT Income Statement

Revenue, Net:47830000
Revenue Per Share:0.3344
Cost of Goods & Services Sold:14907000
Selling, General & Admin Expense:21513000
Research & Development Expense:35658000
Total Operating Expenses:93261000
Operating Income:-45431000
Net Income:-45319000
Earnings Per Share, Basic:-0.32
Shares Outstanding, Basic Avg:143012157

ADPT Cash Flow

Operating Activities Net Income:
Change in Accounts Receiveable:2836000
Net Cash from Operations:-42408000
Net Cash from Operations Per Share:-0.2965
Net Cash from Financing Activities:125520000
Property, Plant & Equipment Purchases:5432000
Net Cash from Investing Activities:58015000
Net Change in Cash & Equivalents:141127000

ADPT Balance Sheet

Cash and Cash Equivalents:219985000
Accounts Receivable, Net:26549000
Inventories:17345000
Total Current Assets:564380000
Property, Plant & Equipment, Net:86662000
Total Assets:884208000
Accounts Payable:4163000
Total Short-Term Liabilities:104018000
Total Liabilities:396394000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Viking Global Investors Lp
29,993,708 sh
 
$213,555
Vanguard Group Inc
11,671,783 sh
95,409 sh
1%
$83,104
-$10,550
Matrix Capital Management Company, Lp
11,572,590 sh
 
$82,397
Blackrock Inc.
10,119,409 sh
1,098,301 sh
12%
$72,051
-$931
Ark Investment Management LLC
9,336,619 sh
563,601 sh
6%
$66,477
-$2,128
Nikko Asset Management Americas, Inc.
4,838,191 sh
219,792 sh
5%
$33,238
-$2,878
Sumitomo Mitsui Trust Holdings, Inc.
4,838,191 sh
219,792 sh
5%
$34,448
-$2,915
Blue Water Life Science Advisors, LLC
3,600,434 sh
480,000 sh
15%
$25,635
$391
Bellevue Group Ag
3,279,620 sh
-259,435 sh
-7%
$23,351
-$5,280
State Street Corp
2,476,435 sh
137,051 sh
6%
$17,632
-$1,294
Geode Capital Management, LLC
2,050,178 sh
19,793 sh
1%
$14,597
-$1,828
Goldman Sachs Group Inc
1,906,589 sh
566,107 sh
42%
$13,575
$2,730
Aristotle Atlantic Partners, LLC
1,894,395 sh
565,127 sh
43%
$13,488
$2,734
Price T Rowe Associates Inc /Md/
1,892,084 sh
-10,291,811 sh
-84%
$13,472
-$85,096
Federated Hermes, Inc.
1,401,339 sh
3,806 sh
0%
$9,978
-$1,328
Principal Financial Group Inc
1,314,279 sh
113,217 sh
9%
$9,358
-$359
Eagle Health Investments LP
1,214,860 sh
 
$8,650
Massachusetts Financial Services Co /Ma/
1,213,915 sh
370,839 sh
44%
$8,644
$1,824
Northern Trust Corp
1,165,834 sh
701,576 sh
151%
$8,301
$1,858
Morgan Stanley
1,021,461 sh
-125,905 sh
-11%
$7,274
-$2,008

Data imported from Adaptive Biotechnologies Corp SEC filings. Check original filings before making any investment decision.